posted on 2007-07-06, 00:00authored byJavier Adrio, Carmen Cuevas, Ignacio Manzanares, Madeleine M. Joullié
Tamandarins A and B are a class of marine natural cyclodepsipeptides with structures and biological
activities closely related to those of the didemnins. The easier synthetic access to tamandarins accelerates
the preparation of new macrocyclic derivatives of this family of antitumor, antiviral, and immunosuppressive compounds. The optimization of the previously reported synthetic route to tamandarins by
changing the macrolactamization site from Nst1 and Thr6 to Pro4 and N,O-Me2Tyr5 residues led to a
significant improvement in the reaction yield. Using this new synthetic approach, four new macrocyclic
analogues of tamandarin B were prepared and evaluated for anticancer activity. These results provide
further insight into the structure−activity relationship of the tamandarins and didemnins.